- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03762304
The Effect of Household-based Screening on Blood Pressure Changes in South Africa
The Effect of Household-based Screening on Blood Pressure Changes in South Africa: a Regression Discontinuity Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Household-based screening and referral to care for blood pressure may improve blood pressure control at the population level in many low- and middle-income countries.
This observational study will use a quasi-experimental regression discontinuity design to evaluate the effect of household-based screening for blood pressure with care encouragement for potentially hypertensive individuals on subsequent changes in blood pressure over time.
Individuals had their blood pressure measured in the household as part of the National Income Dynamics Study data collection. If individuals had a measured blood pressure in the hypertensive zone, they were told that they had elevated blood pressure, that high blood pressure can lead to life threatening consequences, and that they should seek further care. The study exploits the fact that individuals were given this information based on a hard blood pressure cutoff. Therefore, the investigators will evaluate the causal effect of this household-based intervention in the absence of randomization by comparing individuals with a baseline blood pressure just above and below the cut off.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age greater than or equal to 30
- Valid blood pressure measurements
Exclusion Criteria:
- Prior diagnosis of hypertension
- Currently taking medication for blood pressure
- Measured with a blood pressure above 140 mmHg systolic or 90 mmHg diastolic in a previous wave of data
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Intervention group
The intervention group consists of individuals with a measured blood pressure just above the hypertensive cut-off of 140 mmHg systolic or 90 mmHg diastolic blood pressure who have never previously been diagnosed as hypertensive and are not taking medication to lower their blood pressure.
The exact upper bound on blood pressure will be determined empirically.
Individuals in the intervention group were told that that their blood pressure was high, that high blood pressure can lead to life threatening consequences, that blood pressure control can reduce these negative consequences, and that they should seek follow-up care for their blood pressure.
|
During the household survey visit, survey enumerators collected two measurements of the respondent's blood pressure.
If either of the measurements exceeded 140 mmHg systolic or 90 mmHg diastolic, enumerators told participants: "Your blood pressure readings are higher than normal.
High blood pressure is dangerous because it makes the heart work too hard.
High blood pressure increases the risk of heart disease and stroke.
High blood pressure can also cause other problems, such as heart failure, kidney disease, and blindness.
You can control high blood pressure by taking action."
Then the enumerators recommend that an individual seek medical care within 2 months.
|
Control group
The control group consists of individuals with a measured blood pressure just below the hypertensive cut-off of 140 mmHg systolic and 90 mmHg diastolic blood pressure who have never previously been diagnosed as hypertensive and are not taking medication to lower their blood pressure.
The exact lower bound on blood pressure will be determined empirically.
These individuals were not given the care encouragement intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Two-year change in systolic blood pressure
Time Frame: Approximately two years based on the difference between survey waves in the years 2008, 2010, 2012, 2014, and 2017
|
For each survey wave, blood pressure is measured at the household by a trained enumerator using an electronic blood pressure device.
The enumerators take two separate measurements during the course of the visit with at least three minutes between measurements with individuals in a seated position.
The investigators will take the average of the two systolic blood pressure measurements as their main outcome measure.
|
Approximately two years based on the difference between survey waves in the years 2008, 2010, 2012, 2014, and 2017
|
Nine-year change in systolic blood pressure
Time Frame: Baseline in 2008 and approximately nine years later in 2017.
|
For each survey wave, blood pressure is measured at the household by a trained enumerator using an electronic blood pressure device.
The enumerators take two separate measurements during the course of the visit with at least three minutes between measurements with individuals in a seated position.
The investigators will take the average of the two systolic blood pressure measurements as their main outcome measure.
|
Baseline in 2008 and approximately nine years later in 2017.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health-seeking behavior
Time Frame: Cross-sectionally in 2010, 2012, 2014, and 2018
|
Health-care utilization is measured at the household based on respondents' answer to the survey question: "When did you last consult someone about your health?"
|
Cross-sectionally in 2010, 2012, 2014, and 2018
|
Blood pressure treatment
Time Frame: Cross-sectionally in 2010, 2012, 2014, and 2018
|
Whether an individual is currently taking treatment to control their blood pressure is measured during the household survey based on the answer to the question: "Are you currently taking medicine for high blood pressure?"
|
Cross-sectionally in 2010, 2012, 2014, and 2018
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nikkil Sudharsanan, PhD, Research group leader
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RDD - BP - South Africa
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
Clinical Trials on Household blood pressure screening with care encouragement
-
University of Alabama at BirminghamNational Eye Institute (NEI)Completed
-
Omron Healthcare Co., Ltd.ICON plcCompleted
-
The Affiliated Hospital of Qingdao UniversityRecruiting
-
North-West University, South AfricaUniversity of Zurich; University of Cape Town; Medical Research Council, South... and other collaboratorsRecruitingHypertension | Obesity, Childhood | Obesity, AdolescentSouth Africa, Switzerland
-
Cedars-Sinai Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); University of Texas Southwestern... and other collaboratorsCompleted
-
Université de Reims Champagne-ArdenneNot yet recruiting
-
FANG HENot yet recruitingPreeclampsia | stage1 HypertensionChina
-
Nationwide Children's HospitalCompleted
-
Mayo ClinicCompletedHypertension | DiabetesUnited States